CCR5 and AIDS: Together, our paper published in Molecular Medicine, O’Brien’s Science paper, and papers reporting independent discoveries of CCR5Δ32 by the groups of Marc Parmentier in Brussels in Nature, and Rick Koup at the Aaron Diamond AIDS Research Center in Cell provided strong proof of principle for targeting CCR5 in the treatment of patients with HIV/AIDS (10, 12).